The Hippo pathway controls organ size in diverse species, whereas pathway deregulation
can induce tumours in model organisms and occurs in a broad range of human carcinomas, …

The incidence of osteosarcoma is increased 500-fold in patients who inherit mutations in
the RB gene. To understand why the retinoblastoma protein (pRb) is specifically targeted in …

The molecular basis for the inverse relationship between differentiation and tumorigenesis
is unknown. The function of runx2, a master regulator of osteoblast differentiation belonging …

For the past 30 years, improvements in the survival of patients with osteosarcoma have
been mostly incremental. Despite evidence of genomic instability and a high frequency of …

Wnt signaling increases bone mass by stimulating osteoblast lineage commitment and
expansion and forms the basis for novel anabolic therapeutic strategies being developed for …

Methamphetamine intoxication causes long-lasting damage to dopamine nerve endings in
the striatum. The mechanisms underlying this neurotoxicity are not known but oxidative stress …

Purpose: Giant-cell tumor of bone (GCTB) is a locally aggressive, benign osteolytic tumor in
which bone destruction is mediated by RANK ligand (RANKL). The RANKL inhibitor …

Background The development of targeted therapies has created a pressing clinical need for
the rapid and robust molecular characterisation of cancers. We describe here the …

Patient stratification biomarkers that enable the translation of cancer genetic knowledge into
clinical use are essential for the successful and rapid development of emerging targeted …

Background Tenosynovial giant cell tumour (TGCT), a rare, locally aggressive neoplasm,
overexpresses colony-stimulating factor 1 (CSF1). Surgery is standard with no approved …